Form 4: Guardant Health CLO Executes RSU Vesting Transaction

Chief Legal Officer John G. Saia acquired 1,020 shares of Guardant Health common stock via RSU vesting, with 535 shares withheld for taxes.

Summary

• John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported the vesting of 1,020 restricted stock units (RSUs) on June 15, 2026.
• The company withheld 535 shares to satisfy tax obligations related to the vesting event.
• The net increase in the reporting person's direct holdings was 485 shares.
• Following the transaction, the reporting person holds 36,435 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing related to executive compensation, having no material impact on the company's financial health or strategic direction.

Positives

• The transaction reflects the standard vesting of equity compensation, indicating alignment between executive interests and long-term company performance.

Negatives

• The company withheld 535 shares to cover tax liabilities, which is a standard administrative procedure but reduces the net shares acquired by the executive.

Risks

• None identified; this is a routine regulatory disclosure regarding executive compensation.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine RSU vesting disclosures are standard for publicly traded biotech firms and do not typically signal changes in corporate strategy or market outlook.

Comparison to Industry Standards

• The transaction follows standard industry practices for executive equity compensation and tax withholding protocols.
• The vesting schedule aligns with typical three-year equity grant structures observed in the healthcare and biotechnology sectors.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• None mentioned.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units, SEC Filing